Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Perfusion Imaging | 19 | 2023 | 27 | 9.350 |
Why?
|
| Coronary Artery Disease | 12 | 2023 | 56 | 6.350 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 19 | 2023 | 37 | 6.030 |
Why?
|
| Purines | 11 | 2020 | 26 | 4.020 |
Why?
|
| Pyrazoles | 11 | 2020 | 35 | 3.980 |
Why?
|
| Myocardial Ischemia | 7 | 2020 | 24 | 3.320 |
Why?
|
| Kidney Failure, Chronic | 5 | 2023 | 61 | 2.910 |
Why?
|
| Myocardial Infarction | 7 | 2023 | 64 | 2.330 |
Why?
|
| Thrombosis | 5 | 2018 | 33 | 2.170 |
Why?
|
| Heart Failure | 8 | 2020 | 77 | 2.160 |
Why?
|
| Humans | 58 | 2023 | 12240 | 2.000 |
Why?
|
| Exercise Test | 11 | 2020 | 62 | 1.980 |
Why?
|
| Atrial Fibrillation | 6 | 2022 | 57 | 1.900 |
Why?
|
| Prognosis | 15 | 2023 | 363 | 1.760 |
Why?
|
| Middle Aged | 27 | 2022 | 4043 | 1.520 |
Why?
|
| Female | 33 | 2022 | 6974 | 1.430 |
Why?
|
| Atrial Appendage | 5 | 2022 | 13 | 1.430 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 51 | 1.380 |
Why?
|
| Male | 32 | 2022 | 6815 | 1.380 |
Why?
|
| Aminophylline | 4 | 2017 | 5 | 1.380 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 26 | 1.280 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 19 | 1.150 |
Why?
|
| Retrospective Studies | 15 | 2023 | 1467 | 1.140 |
Why?
|
| Stroke Volume | 6 | 2020 | 26 | 1.050 |
Why?
|
| Aged | 19 | 2022 | 4000 | 1.040 |
Why?
|
| Reproducibility of Results | 9 | 2018 | 324 | 0.920 |
Why?
|
| Risk Assessment | 9 | 2021 | 295 | 0.900 |
Why?
|
| Cardiology | 4 | 2019 | 26 | 0.900 |
Why?
|
| Nuclear Medicine | 3 | 2019 | 4 | 0.880 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2021 | 5 | 0.830 |
Why?
|
| Angina Pectoris | 2 | 2023 | 8 | 0.830 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 20 | 0.780 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2021 | 7 | 0.780 |
Why?
|
| Diagnostic Imaging | 2 | 2021 | 43 | 0.760 |
Why?
|
| Adenosine A2 Receptor Agonists | 3 | 2017 | 5 | 0.730 |
Why?
|
| Pulmonary Embolism | 3 | 2021 | 32 | 0.730 |
Why?
|
| Medicaid | 2 | 2020 | 23 | 0.730 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 166 | 0.720 |
Why?
|
| Heart-Assist Devices | 2 | 2019 | 10 | 0.720 |
Why?
|
| Medicare | 2 | 2019 | 59 | 0.710 |
Why?
|
| Heart | 3 | 2021 | 42 | 0.700 |
Why?
|
| Primary Health Care | 2 | 2013 | 35 | 0.680 |
Why?
|
| Prospective Studies | 9 | 2019 | 817 | 0.680 |
Why?
|
| Image Enhancement | 2 | 2018 | 25 | 0.670 |
Why?
|
| Coronary Vessels | 1 | 2021 | 17 | 0.670 |
Why?
|
| Liver Transplantation | 1 | 2021 | 30 | 0.660 |
Why?
|
| Risk Factors | 9 | 2021 | 1049 | 0.650 |
Why?
|
| Atrioventricular Node | 1 | 2020 | 2 | 0.640 |
Why?
|
| Diltiazem | 1 | 2020 | 6 | 0.640 |
Why?
|
| Hyperkalemia | 1 | 2020 | 5 | 0.640 |
Why?
|
| Bradycardia | 1 | 2020 | 15 | 0.630 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 15 | 0.630 |
Why?
|
| Treatment Outcome | 13 | 2022 | 1478 | 0.630 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2020 | 13 | 0.630 |
Why?
|
| Insurance Coverage | 1 | 2020 | 7 | 0.630 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 5 | 0.630 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 38 | 0.620 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 3 | 0.610 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2019 | 1 | 0.610 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 7 | 0.600 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 252 | 0.600 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 19 | 0.600 |
Why?
|
| United States | 8 | 2020 | 989 | 0.600 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 2 | 0.580 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 6 | 0.580 |
Why?
|
| Patient Selection | 2 | 2021 | 111 | 0.570 |
Why?
|
| Contrast Media | 1 | 2018 | 32 | 0.570 |
Why?
|
| Heart Diseases | 1 | 2018 | 31 | 0.560 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 19 | 0.520 |
Why?
|
| Coronary Angiography | 4 | 2023 | 30 | 0.510 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2017 | 1 | 0.510 |
Why?
|
| Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2017 | 2 | 0.510 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.510 |
Why?
|
| Accreditation | 1 | 2016 | 9 | 0.500 |
Why?
|
| Electrocardiography | 2 | 2015 | 47 | 0.480 |
Why?
|
| Echocardiography, Doppler | 1 | 2016 | 5 | 0.480 |
Why?
|
| Mitral Valve | 1 | 2016 | 4 | 0.480 |
Why?
|
| Hemodynamics | 1 | 2016 | 29 | 0.480 |
Why?
|
| Cohort Studies | 6 | 2019 | 827 | 0.480 |
Why?
|
| Heart Rate | 1 | 2016 | 55 | 0.470 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2016 | 2 | 0.470 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2015 | 2 | 0.470 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 6 | 0.470 |
Why?
|
| Adult | 7 | 2020 | 3557 | 0.460 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 128 | 0.460 |
Why?
|
| Insurance Carriers | 1 | 2015 | 1 | 0.450 |
Why?
|
| Technetium | 1 | 2015 | 3 | 0.450 |
Why?
|
| Social Class | 1 | 2015 | 24 | 0.440 |
Why?
|
| Troponin I | 1 | 2015 | 7 | 0.440 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 16 | 0.440 |
Why?
|
| Registries | 3 | 2020 | 88 | 0.430 |
Why?
|
| Myocardium | 1 | 2015 | 81 | 0.420 |
Why?
|
| Rheumatic Heart Disease | 1 | 2014 | 2 | 0.420 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 11 | 0.410 |
Why?
|
| Hyperemia | 1 | 2014 | 2 | 0.410 |
Why?
|
| Biomarkers | 5 | 2021 | 294 | 0.410 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 12 | 0.410 |
Why?
|
| Urban Population | 1 | 2014 | 78 | 0.400 |
Why?
|
| Diabetes Complications | 1 | 2013 | 28 | 0.390 |
Why?
|
| Perfusion | 3 | 2020 | 10 | 0.390 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 218 | 0.380 |
Why?
|
| Comorbidity | 4 | 2021 | 209 | 0.370 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 2152 | 0.370 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 726 | 0.360 |
Why?
|
| Angina, Unstable | 2 | 2002 | 5 | 0.360 |
Why?
|
| Abdominal Pain | 1 | 2012 | 3 | 0.360 |
Why?
|
| Diarrhea | 1 | 2012 | 20 | 0.360 |
Why?
|
| Vasodilator Agents | 3 | 2016 | 13 | 0.340 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2022 | 5 | 0.330 |
Why?
|
| Physicians' Offices | 1 | 2010 | 2 | 0.330 |
Why?
|
| Observational Studies as Topic | 3 | 2019 | 14 | 0.320 |
Why?
|
| Ambulatory Care | 1 | 2010 | 36 | 0.320 |
Why?
|
| Hospitalization | 4 | 2021 | 158 | 0.310 |
Why?
|
| Double-Blind Method | 3 | 2016 | 166 | 0.300 |
Why?
|
| Chicago | 3 | 2015 | 453 | 0.290 |
Why?
|
| Troponin | 3 | 2021 | 10 | 0.270 |
Why?
|
| ROC Curve | 2 | 2016 | 78 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 85 | 0.220 |
Why?
|
| Time Factors | 3 | 2019 | 695 | 0.220 |
Why?
|
| Survival Rate | 2 | 2015 | 152 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 116 | 0.210 |
Why?
|
| Incidence | 2 | 2015 | 338 | 0.210 |
Why?
|
| Radiopharmaceuticals | 2 | 2015 | 27 | 0.210 |
Why?
|
| Guideline Adherence | 2 | 2014 | 30 | 0.200 |
Why?
|
| Stroke | 2 | 2022 | 117 | 0.200 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 400 | 0.200 |
Why?
|
| Prevalence | 2 | 2015 | 175 | 0.200 |
Why?
|
| Dyspnea | 1 | 2023 | 22 | 0.200 |
Why?
|
| Placebo Effect | 2 | 2014 | 5 | 0.190 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 5 | 0.190 |
Why?
|
| Pericardium | 2 | 2021 | 12 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2021 | 72 | 0.190 |
Why?
|
| Pulmonary Veins | 1 | 2022 | 6 | 0.190 |
Why?
|
| Patient Discharge | 2 | 2019 | 77 | 0.180 |
Why?
|
| Algorithms | 1 | 2002 | 169 | 0.170 |
Why?
|
| Risk | 2 | 2020 | 97 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2021 | 41 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2021 | 64 | 0.160 |
Why?
|
| Ischemia | 1 | 2020 | 10 | 0.160 |
Why?
|
| Syndrome | 1 | 2020 | 40 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 26 | 0.160 |
Why?
|
| Utilization Review | 1 | 2020 | 1 | 0.160 |
Why?
|
| Electric Countershock | 1 | 2020 | 6 | 0.160 |
Why?
|
| Prospective Payment System | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ventriculography, First-Pass | 1 | 2019 | 1 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 12 | 0.150 |
Why?
|
| Kidney | 1 | 2020 | 87 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 6 | 0.150 |
Why?
|
| Health Resources | 1 | 2019 | 14 | 0.150 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2019 | 2 | 0.150 |
Why?
|
| Acute Disease | 2 | 2021 | 90 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 8 | 0.150 |
Why?
|
| Outpatients | 1 | 2019 | 24 | 0.150 |
Why?
|
| Hospitals | 1 | 2019 | 68 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2019 | 186 | 0.150 |
Why?
|
| Publication Bias | 1 | 2019 | 3 | 0.150 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 7 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2019 | 9 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 13 | 0.140 |
Why?
|
| Hospice Care | 1 | 2019 | 15 | 0.140 |
Why?
|
| Calcium | 1 | 2021 | 288 | 0.140 |
Why?
|
| Myocardial Revascularization | 2 | 2020 | 9 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2019 | 48 | 0.140 |
Why?
|
| Palliative Care | 1 | 2019 | 53 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 36 | 0.140 |
Why?
|
| Veterans | 1 | 2019 | 52 | 0.140 |
Why?
|
| Illinois | 2 | 2021 | 110 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 10 | 0.130 |
Why?
|
| Patient Safety | 1 | 2017 | 16 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2015 | 105 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Perfusion Imaging | 1 | 2016 | 3 | 0.120 |
Why?
|
| Organophosphorus Compounds | 1 | 2016 | 4 | 0.120 |
Why?
|
| Organotechnetium Compounds | 1 | 2016 | 6 | 0.120 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 13 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2016 | 39 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 84 | 0.120 |
Why?
|
| Age Distribution | 1 | 2015 | 25 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 4 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2015 | 46 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2015 | 34 | 0.120 |
Why?
|
| Workload | 1 | 2015 | 12 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2016 | 29 | 0.110 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 6 | 0.110 |
Why?
|
| Rest | 1 | 2015 | 19 | 0.110 |
Why?
|
| Surgeons | 1 | 2015 | 43 | 0.110 |
Why?
|
| Health Services Misuse | 1 | 2015 | 1 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 73 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 46 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 141 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2015 | 42 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 68 | 0.110 |
Why?
|
| Population Groups | 1 | 2014 | 3 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2014 | 75 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2014 | 214 | 0.100 |
Why?
|
| Decision Making | 1 | 2015 | 95 | 0.100 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2013 | 6 | 0.100 |
Why?
|
| Dilatation | 1 | 2013 | 3 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 66 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 423 | 0.100 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 161 | 0.100 |
Why?
|
| Cause of Death | 1 | 2013 | 32 | 0.090 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2012 | 1 | 0.090 |
Why?
|
| Premedication | 1 | 2012 | 2 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2012 | 16 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 16 | 0.090 |
Why?
|
| Child | 1 | 2014 | 614 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 152 | 0.090 |
Why?
|
| Young Adult | 1 | 2014 | 863 | 0.080 |
Why?
|
| Adolescent | 1 | 2014 | 989 | 0.080 |
Why?
|
| Safety | 1 | 2010 | 14 | 0.080 |
Why?
|
| Diastole | 1 | 2010 | 24 | 0.080 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 54 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 82 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2022 | 113 | 0.070 |
Why?
|
| Lasers | 1 | 2022 | 9 | 0.050 |
Why?
|
| Hematologic Agents | 1 | 2002 | 1 | 0.050 |
Why?
|
| Vitamin K | 1 | 2022 | 2 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2002 | 20 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2022 | 55 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 32 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 42 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 78 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 27 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2021 | 50 | 0.040 |
Why?
|
| Journal Impact Factor | 1 | 2020 | 5 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 12 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 119 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 29 | 0.040 |
Why?
|
| Data Accuracy | 1 | 2019 | 3 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2019 | 12 | 0.040 |
Why?
|
| Equipment Design | 1 | 2019 | 76 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 56 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 156 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 126 | 0.040 |
Why?
|
| Software | 1 | 2018 | 26 | 0.040 |
Why?
|
| Internet | 1 | 2018 | 30 | 0.030 |
Why?
|
| Research Report | 1 | 2017 | 4 | 0.030 |
Why?
|
| Current Procedural Terminology | 1 | 2015 | 5 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 17 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 85 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 175 | 0.020 |
Why?
|